ALPS Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,415
Closed -$240K – 1115
2022
Q4
$240K Sell
1,415
-10
-0.7% -$1.81K ﹤0.01% 976
2022
Q3
$267K Buy
+1,425
New +$300K ﹤0.01% 955
2022
Q1
– Sell
-1,260
Closed -$334K – 939
2021
Q4
$334K Buy
1,260
+26
+2% +$7K ﹤0.01% 807
2021
Q3
$357K Sell
1,234
-482
-28% -$124K ﹤0.01% 692
2021
Q2
$343K Hold
1,716
– – ﹤0.01% 728
2021
Q1
$334K Buy
+1,716
New +$352K ﹤0.01% 692
2018
Q3
– Sell
-12,743
Closed -$599K – 1059
2018
Q2
$599K Sell
12,743
-600
-4% -$24.7K ﹤0.01% 489
2018
Q1
$483K Buy
+13,343
New +$469K ﹤0.01% 546
2014
Q3
– Sell
-38,763
Closed -$883K – 682
2014
Q2
$883K Buy
38,763
+988
+3% +$17.6K 0.01% 154
2014
Q1
$486K Sell
37,775
-10,385
-22% -$149K ﹤0.01% 546
2013
Q4
$746K Buy
48,160
+23,388
+94% +$279K 0.01% 151
2013
Q3
$275K Buy
+24,772
New +$247K ﹤0.01% 219

Other funds holding RGEN

ALPS Advisors's RGEN Position: Q1 2023 in Review

ALPS Advisors sold out of Repligen (RGEN) in Q1 2023, closing a stake of 1,415 shares — an estimated $240K sold.

ALPS Advisors first reported a position in RGEN in Q3 2013 and held it in 12 quarters. The position peaked at $883K in Q2 2014. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • ALPS Advisors reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • ALPS Advisors sold 1,415 Repligen shares in Q1 2023, an estimated $240K.
  • ALPS Advisors first reported a position in Repligen in Q3 2013 and held it in 12 quarters.
  • ALPS Advisors's Repligen position peaked at $883K in Q2 2014.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on ALPS Advisors's 13F filing for Q1 2023, filed 10 May 2023.